Page 3 - Alvogen Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights -March 28, 2024 at 08:04 am EDT

Four potential near-term milestones, including data from two clinical trials, an NDA filing and a share dividend RADNOR, Pa., March 28, 2024 /PRNewswire/ NRx Pharmaceuticals, Inc. , a.

United statesStephen willardTherapeutics incNrx pharmaceuticalsSource nrx pharmaceuticals incSecurities exchangeUs national institutes of healthUs patient centered outcomes research initiativeNephron pharmaceuticalsAlvogen incExchange commissionLotus pharmaceuticals incNrxp nrx pharmaceuticalsPrnewswire nrx pharmaceuticals incSpecialty pharmaceutical companyCompany board of directors

NRx Pharmaceuticals (NRXP) Reports Prelim FY23 Results

NRx Pharmaceuticals (NRXP) Reports Prelim FY23 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJanet rehnquistStephen willardNrx pharmaceuticals incSecurities exchangeUs patient centered outcomes research initiativeCompany board of directorsNephron pharmaceuticalsLotus pharmaceuticals incAlvogen incUs national institutes of healthSpecialty pharmaceutical companyNrx pharmaceuticalsExchange commissionTherapeutics incSource nrx pharmaceuticals inc

NRx Pharmaceuticals (NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical

NRx Pharmaceuticals (NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesStephen willardAsia pacificJp morganNrx pharmaceuticalsLotus pharmaceutical coWorld health organizationNrx pharmaceuticals incAlvogen incLotus pharmaceuticalChief executive officer

NRx Pharmaceuticals, Inc (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co Ltd (1975 TW) in Recent Financial Report

NRx Pharmaceuticals, Inc (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co Ltd (1975 TW) in Recent Financial Report
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoStephen willardAsia pacificSource nrx pharmaceuticals incNrxp nrx pharmaceuticalsPrnewswire nrx pharmaceuticals incJp morganAlvogen incNrx pharmaceuticalsUs national institutes of healthLotus pharmaceutical coNrx pharmaceuticals incWorld health organizationLotus pharmaceuticalChief executive officer

NRx Pharmaceuticals, Inc (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co Ltd (1975 TW) in Recent Financial Report -February 09, 2024 at 08:31 am EST

Companies continue to work collaboratively to advance NRX-101 in bipolar depression with suicidalityLotus notes that NRx has achieved a significant milestone by completing enrollment for its phase.

United statesSan franciscoStephen willardAsia pacificSource nrx pharmaceuticals incNrx pharmaceuticalsNrxp nrx pharmaceuticalsWorld health organizationAlvogen incPrnewswire nrx pharmaceuticals incUs national institutes of healthJp morganLotus pharmaceutical coNrx pharmaceuticals incLotus pharmaceuticalChief executive officer